Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 16/20 | 0.55 |
| ▸ | CNR2 | P34972 | 7/20 | 0.55 |
| ▸ | RORC | P51449 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2019886 | 0.87 | CNR1 (0.67) | CNR1CNR2 | |
| SCHEMBL2017252 | 0.78 | CNR1 (0.64) | CNR1CNR2 | |
| SCHEMBL2024845 | 0.77 | CNR1 (0.79) | CNR1CNR2 | |
| SCHEMBL2018742 | 0.71 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL2018744 | 0.71 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL2018952 | 0.71 | CNR1 (1.00) | CNR1CNR2 | |
| SCHEMBL14260009 | 0.70 | CNR1 (0.68) | CNR1CNR2 | |
| SCHEMBL2022005 | 0.70 | RORC (0.34) | RORCKDM4E | |
| SCHEMBL14259956 | 0.67 | CNR1 (0.61) | CNR1CNR2 | |
| SCHEMBL2021252 | 0.66 | CNR1 (0.55) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110160180-A1 | Cannabinoid Receptor Ligands | ASTRAZENECA AB (SE) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160180-A1 | Cannabinoid Receptor Ligands | CNR1, CNR2, OPRL1 | CNR1 1/4885CNR2 2/4885RORC 574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.